Agomelatine Cuts Ocular Pressure With Glaucoma

This article originally appeared here.
Share this content:
Agomelatine Cuts Ocular Pressure With Glaucoma
Agomelatine Cuts Ocular Pressure With Glaucoma

FRIDAY, April 10, 2015 (HealthDay News) -- Oral systemic agomelatine has a hypotensive effect that decreases intraocular pressure (IOP) in both eyes of treatment-resistant primary open angle glaucoma (POAG) patients, according to a study published in the March issue of Ophthalmic & Physiological Optics.

Nicola Pescosolido, M.D., from the Università di Roma La Sapienza, and colleagues studied 10 patients affected by hypertensive POAG treated with multiple hypotensive topical drugs, and under further treatment with agomelatine (25 mg day−1 per os) for psychiatric problems. IOP tonometric values were measured at baseline and after 15 and 30 days of agomelatine supplementation.

The researchers found that oral agomelatine showed a significant hypotonising effect, consistently decreasing IOP by roughly 30 percent of the enrollment value at 15 and 30 days of treatment.

"The hypotonising effect of oral systemic agomelatine at 25 mg day−1 was able to further decrease IOP in both eyes of all enrolled POAG patients in which multiple drug treatment with anti-glaucoma eye drops had no further effect," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Florida Teen First Human Case of Another Mosquito-Borne Virus

Florida Teen First Human Case of Another Mosquito-Borne ...

First documented case of Keystone infection in a human

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

Illnesses reported in Illinois, Indiana, Kentucky, Michigan, Missouri, Ohio, and Tennessee

AAFP Still Recommends CRC Screening From Age 50 to 75

AAFP Still Recommends CRC Screening From Age 50 ...

Despite ACS change to start screening from age 45 years, AAFP agrees with USPSTF recommendation

is free, fast, and customized just for you!




Already a member?

Sign In Now »